Fredag 25 April | 18:38:15 Europe / Stockholm

Kalender

Est. tid*
2025-11-14 08:30 Kvartalsrapport 2025-Q3
2025-08-29 08:30 Kvartalsrapport 2025-Q2
2025-05-14 08:30 Kvartalsrapport 2025-Q1
2025-04-28 N/A X-dag ordinarie utdelning OMDA 0.00 NOK
2025-04-25 N/A Årsstämma
2025-02-26 - Bokslutskommuniké 2024
2024-11-25 - Extra Bolagsstämma 2024
2024-11-08 - Kvartalsrapport 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-04-29 - X-dag ordinarie utdelning OMDA 0.48 NOK
2024-04-25 - Årsstämma
2024-03-01 - Bokslutskommuniké 2023
2023-11-10 - Kvartalsrapport 2023-Q3
2023-09-26 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-12 - Kvartalsrapport 2023-Q1
2023-04-28 - X-dag ordinarie utdelning OMDA 0.00 NOK
2023-04-27 - Årsstämma
2023-02-28 - Bokslutskommuniké 2022
2022-11-30 - Kvartalsrapport 2022-Q3
2022-10-03 - Extra Bolagsstämma 2022
2022-08-30 - Kvartalsrapport 2022-Q2
2022-05-20 - X-dag ordinarie utdelning OMDA 0.00 NOK
2022-05-19 - Årsstämma
2022-05-19 - Kvartalsrapport 2022-Q1
2022-02-25 - Bokslutskommuniké 2021
2021-11-26 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-26 - Kvartalsrapport 2021-Q1
2021-05-07 - X-dag ordinarie utdelning OMDA 0.00 NOK
2021-05-06 - Årsstämma
2021-02-26 - Bokslutskommuniké 2020
2020-12-11 - Extra Bolagsstämma 2020
2020-11-27 - Kvartalsrapport 2020-Q3

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorInformationsteknik
IndustriProgramvara
OMDA är verksamma inom teknikbranschen. Bolaget är specialiserade inom utveckling av digitala plattformar för vården. Programvaran är egenutvecklad och används huvudsakligen för analys och uppföljning av olika områden inom sjukvården. Utöver huvudverksamheten erbjuds även diverse mervärdestjänster. Verksamhet innehas på global nivå med störst närvaro inom den europeiska marknaden.
2024-08-23 07:00:00
Oslo, Norway, 23 August 2024: Today, Omda AS ("Omda"), a leading provider of
specialised software for healthcare and emergency response, published its
results for the second quarter of 2024.

Omda continues to benefit from its long-standing customer relationships and
posts revenue of 104 MNOK, of which 83 MNOK (80%) stems from recurring revenue.
The reported revenue and the EBITDA margin of 10% are at par with the Q2-23
results. Organic growth for the quarter was 5% in local currency, and 7% over
the last four quarters.

Omda CEO Sverre Flatby comments: "Stable organic growth and long-term recurring
revenue with minor churn continue to be predictable."

In Q2-24, Omda obtained Medical Device Regulation (MDR) certification.

"Our MDR certification, recognised as the highest standard in our industry,
reaffirms our position as the leading specialist software provider in our niche
markets," Flatby says.

Highlights from the report:
o Q2-24 total income 104 MNOK, at par with Q2-23
o Recurring revenue of 83 MNOK, accounting for 80% of total sales
o Reported EBITDA was 10 MNOK resulting in a 10% EBITDA margin
o YTD EBITDA margin increased from 8% to 12% compared to H1-23
o Q2-24 organic growth of 5% vs Q2-23 in local currency (4% in NOK)
o Gross margin increased to 93% (91%)
o Omda received Medical Device Regulation (MDR) certification
o Omda signed agreement to divest operations in the Philippines

For more information, please contact:
Einar Bonnevie
Chief Financial Officer
+47 91 55 45 32
einar.bonnevie@omda.com

About Omda
Omda is the leading provider of specialised software for healthcare and
emergency services in the Nordics with a growing presence in Europe, North
America and the Pacific region. The company has more than 500 customers in 27
countries and employs almost 300 dedicated specialists. Our highly specialised
healthcare solutions empower medical professionals and emergency responders,
enabling them to know more and work smarter. With a focus on user-centric
design, value-driven development and close working relationships with customers,
Omda delivers solutions that enhance patient safety and improve healthcare
outcomes.

For more information, visit www.omda.com
Follow us on LinkedIn
Subscribe to our newsletter: http://eepurl.com/dsoOJH